Dermisonics, Inc.
OTC: DMSI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Bruce H. Haglund
- Headquarters
- Irvine, United States
- IPO year
- 2003
- Market cap
- $1.9K
- Website
- http://www.dermisonics.com
Loading DMSI…
Loading profile data…Frequently asked questions about DMSI
What does Dermisonics, Inc. (DMSI) do?
Dermisonics, Inc. develops and produces ultrasonic technologies and equipment for the transdermal administration of medications. A core focus for the company is the creation, evaluation, and market launch of its unique active transdermal patch, known as the U-Strip. This innovative patch is designed to facilitate the needle-free entry of large m...
Where does DMSI trade?
Dermisonics, Inc. (DMSI) trades on the Other OTC.
What sector is DMSI in?
Dermisonics, Inc. (DMSI) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Dermisonics, Inc.?
Bruce H. Haglund is the chief executive officer of Dermisonics, Inc. (DMSI).
Where is Dermisonics, Inc. headquartered?
Dermisonics, Inc. is headquartered in United States.
Does DMSI pay a dividend?
Dermisonics, Inc. (DMSI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DMSI go public?
Dermisonics, Inc. (DMSI) completed its initial public offering in 2003.